Phreesia (PHR) Projected to Post Quarterly Earnings on Wednesday

Posted by on May 20th, 2026

Phreesia (NYSE:PHR – Get Free Report) will likely be posting its Q1 2027 results before the market opens on Wednesday, May 27th. Analysts expect the company to announce earnings of $0.02 per share and revenue of $130.0770 million for the quarter. Investors are encouraged to explore the company’s upcoming Q1 2027 earning overview page for the latest details on the call scheduled for Wednesday, May 27, 2026 at 5:00 PM ET.

Phreesia (NYSE:PHR – Get Free Report) last released its quarterly earnings results on Monday, March 30th. The company reported $0.02 earnings per share for the quarter, missing the consensus estimate of $0.07 by ($0.05). Phreesia had a net margin of 0.48% and a return on equity of 3.23%. The business had revenue of $127.07 million during the quarter, compared to analysts’ expectations of $126.75 million. During the same period in the previous year, the business earned ($0.11) EPS. The business’s revenue was up 15.9% on a year-over-year basis. On average, analysts expect Phreesia to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Phreesia Stock Up 0.8%

Shares of NYSE PHR opened at $9.15 on Wednesday. Phreesia has a 12 month low of $7.77 and a 12 month high of $32.76. The company has a current ratio of 1.53, a quick ratio of 1.53 and a debt-to-equity ratio of 0.41. The firm has a market capitalization of $565.20 million, a price-to-earnings ratio of 305.00 and a beta of 0.89. The business has a 50-day moving average of $9.82 and a 200-day moving average of $14.27.

Insider Buying and Selling at Phreesia

In related news, General Counsel Allison C. Hoffman sold 6,176 shares of the stock in a transaction on Monday, April 20th. The shares were sold at an average price of $9.06, for a total transaction of $55,954.56. Following the transaction, the general counsel owned 157,309 shares of the company’s stock, valued at approximately $1,425,219.54. This trade represents a 3.78% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider David Linetsky sold 8,332 shares of Phreesia stock in a transaction on Friday, April 10th. The stock was sold at an average price of $8.07, for a total transaction of $67,239.24. Following the completion of the transaction, the insider owned 224,056 shares in the company, valued at approximately $1,808,131.92. The trade was a 3.59% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 50,493 shares of company stock worth $461,983 over the last 90 days. Company insiders own 5.50% of the company’s stock.

Institutional Investors Weigh In On Phreesia

Several institutional investors have recently bought and sold shares of PHR. Raymond James Financial Inc. increased its stake in Phreesia by 2.7% in the 2nd quarter. Raymond James Financial Inc. now owns 14,049 shares of the company’s stock worth $400,000 after purchasing an additional 375 shares during the period. Alliancebernstein L.P. grew its holdings in shares of Phreesia by 1.3% in the third quarter. Alliancebernstein L.P. now owns 62,712 shares of the company’s stock worth $1,475,000 after purchasing an additional 812 shares during the last quarter. Van ECK Associates Corp increased its stake in shares of Phreesia by 78.7% in the fourth quarter. Van ECK Associates Corp now owns 2,502 shares of the company’s stock worth $42,000 after buying an additional 1,102 shares during the period. Deutsche Bank AG raised its holdings in Phreesia by 2.4% during the 4th quarter. Deutsche Bank AG now owns 66,288 shares of the company’s stock valued at $1,122,000 after buying an additional 1,540 shares during the last quarter. Finally, Commerce Bank boosted its position in Phreesia by 12.5% during the 4th quarter. Commerce Bank now owns 16,361 shares of the company’s stock valued at $277,000 after buying an additional 1,815 shares during the period. 92.10% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

PHR has been the subject of several research analyst reports. Stephens dropped their target price on shares of Phreesia from $32.00 to $20.00 and set an “overweight” rating for the company in a research report on Tuesday, March 31st. Barclays restated an “equal weight” rating and set a $10.00 price objective (down from $24.00) on shares of Phreesia in a research report on Thursday, May 14th. Mizuho dropped their price objective on shares of Phreesia from $22.00 to $19.00 and set an “outperform” rating for the company in a report on Tuesday, March 24th. Needham & Company LLC cut their target price on shares of Phreesia from $35.00 to $14.00 and set a “buy” rating for the company in a research report on Tuesday, March 31st. Finally, Wells Fargo & Company reduced their target price on Phreesia from $30.00 to $25.00 and set an “overweight” rating on the stock in a research note on Thursday, March 26th. Eleven research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, Phreesia presently has a consensus rating of “Moderate Buy” and a consensus target price of $20.00.

View Our Latest Stock Analysis on PHR

Key Headlines Impacting Phreesia

Here are the key news stories impacting Phreesia this week:

Phreesia Company Profile

(Get Free Report)

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.

Further Reading

Earnings History for Phreesia (NYSE:PHR)

Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.